Gts Securities LLC Tg Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$17.21 - $25.28 $91,213 - $133,984	5,300 Added 7.15%	79,400 $1.86 Million
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $1.89 Million - $2.72 Million	-141,600 Reduced 65.65%	74,100 $1.32 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $789,012 - $1.29 Million	60,600 Added 39.07%	215,700 $3.28 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $222,444 - $626,373	33,300 Added 27.34%	155,100 $2.65 Million
Q3 2023 Nov 15, 2023	BUY	$8.36 - $26.5 $1.02 Million - $3.23 Million	121,800 New	121,800 $1.02 Million

338

87.7M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.68B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.